This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Nippon Medical School Foundation, Toppan Printing Co., Ltd.. Active years: 2023.
Company Filing History:
1 out of 17 
1 out of 1,269 
Years Active: 2023
Title: Takuma Iwai: Innovator in Tumor Marker Gene Detection
Introduction
Takuma Iwai is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of somatic mutations in tumor marker genes. His innovative approach has the potential to enhance tumor status evaluation methods, providing valuable insights for cancer treatment.
Latest Patents
Iwai holds a patent for a method of detecting somatic mutations in tumor marker genes. This method involves recovering a peripheral blood mononuclear cell layer from a blood sample collected from a subject. It examines whether a nucleic acid derived from tumor marker genes with somatic mutations is detected from the DNA included in the peripheral blood mononuclear cell layer. This groundbreaking technique could revolutionize how tumors are evaluated and monitored.
Career Highlights
Throughout his career, Takuma Iwai has worked with prominent organizations, including Toppan Printing Co., Ltd. and Nippon Medical School Foundation. His experience in these institutions has allowed him to develop and refine his innovative methods in medical diagnostics.
Collaborations
Iwai has collaborated with esteemed colleagues such as Shiro Kitano and Takeshi Yamada. Their combined expertise has contributed to advancements in the field of tumor marker gene detection.
Conclusion
Takuma Iwai's work in detecting somatic mutations in tumor marker genes represents a significant advancement in cancer diagnostics. His innovative methods and collaborations with other experts highlight his commitment to improving medical technology.